Mustang Bio Inc.
Organization details
- Legal name
- Mustang Bio Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Waltham
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MBIO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001680048
- EIN
- 47-3828760
Board of directors
-
Adam J. Chill · DirectorSince 2023
-
David Jin · DirectorSince 2024
-
Lindsay A. Rosenwald M.D. · DirectorSince 2016
-
Manuel Litchman M.D. · Director · President, CEO and Interim CFOSince 2023
-
Michael J. Zelefsky · DirectorSince 2023
-
Michael S. Weiss · DirectorSince 2016
-
Neil Herskowitz · DirectorSince 2023
Chief executives
Director election results
Annual meeting of December 26, 2024. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
98.1%
-
98.1%
-
98.8%
-
98.8%
-
98.9%
-
99.0%
-
99.0%
Board connections
3 of this board's directors also sit on 3 other boards. 3 are in the same sector.
-
Fortress Biotech Inc. Same sectorvia Lindsay A. Rosenwald M.D. and Michael S. Weiss
-
Journey Medical Corporation Same sectorvia Lindsay A. Rosenwald M.D. and Neil Herskowitz
-
TG Therapeutics Inc. Same sectorvia Michael S. Weiss
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $237
- 1 purchase by 1 insider
- Sold, last 12 months
- $241
- 2 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 24, 2026 | Manuel Litchman M.D. Director, Officer (President, CEO and Interim CFO) | Shares withheld for tax | −19 | $0.75 | $14 |
| Jan 2, 2026 | Fortress Biotech, Inc. 10% owner | Grant or award | +278,385 | — | — |
| Dec 30, 2025 | Neil Herskowitz Director | Open-market sale | −247 | $0.96 | $237 |
| Dec 30, 2025 | Adam J. Chill Director | Open-market sale | −4 | $0.95 | $4 |
| Dec 30, 2025 | David Jin Director | Open-market purchase | +247 | $0.96 | $237 |
| Sep 29, 2025 | Fortress Biotech, Inc. 10% owner | Grant or award | +59,334 | — | — |
| Apr 24, 2025 | Manuel Litchman M.D. Director, Officer (President, CEO and Interim CFO) | Shares withheld for tax | −27 | $1.24 | $33 |
| Mar 31, 2025 | Fortress Biotech, Inc. 10% owner | Grant or award | +67,806 | — | — |
| Jun 27, 2024 | Fortress Biotech, Inc. 10% owner | Grant or award | +575,191 | — | — |
| May 31, 2024 | Manuel Litchman M.D. Director, Officer (President and CEO) | Shares withheld for tax | −1,396 | $0.35 | $489 |
| Jan 2, 2024 | Fortress Biotech, Inc. 10% owner | Grant or award | +419,092 | — | — |
| Jul 5, 2023 | Michael J. Zelefsky Director | Grant or award | +7,246 | — | — |
| Jul 5, 2023 | Adam J. Chill Director | Grant or award | +7,246 | — | — |
| Jul 5, 2023 | Lindsay A. Rosenwald M.D. Director | Grant or award | +7,246 | — | — |
| Jul 5, 2023 | Michael S. Weiss Director | Grant or award | +7,246 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Mustang Bio Inc.
Who is the CEO of Mustang Bio Inc.?
Manuel Litchman M.D. is Mustang Bio Inc.'s President and CEO.
How many directors are on Mustang Bio Inc.'s board?
Mustang Bio Inc.'s board has 7 directors: Adam J. Chill, David Jin, Lindsay A. Rosenwald M.D., Manuel Litchman M.D., Michael J. Zelefsky, Michael S. Weiss and Neil Herskowitz.
Are Mustang Bio Inc. insiders buying or selling shares?
Over the last 12 months, Mustang Bio Inc. insiders bought $237 of shares in 1 purchase and sold $241 of shares in 2 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="mustang-bio-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.